JieWangMD

Hematologic Oncology

Physician

Dr. Wang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2014 - 2017
University of MichiganResidency, Internal Medicine, 2010 - 2013
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2010

PubMed

5 citations
TCRvβ-CART therapy mediates high-precision targeting of malignant T-cell clones.
Lauren C Shaw, Mathilde Poussin, Alba Rodriguez-Garcia, Joshua Eggold, Nicholas G Minutolo
Blood Advances. 2023-05-09
Post-irradiation intratumoral heterogeneity modulates response to immune checkpoint inhibition therapy in a murine melanoma model.
Jie Wang, Shivani Sud, Yanli Qu, Liantao Li, Jiajie Zhang
Neoplasia. 2023-02-01
2 citations
Radiosensitivity of Breast Cancer Cells Is Dependent on the Organ Microenvironment.
Genyan Guo, Ryan T Morse, Jie Wang, Xuan Chen, Jiajie Zhang
Frontiers in Oncology. 2022-01-01

Jim’s Journey: The Power of Collaboration in Blood Cancer CareOctober 24th, 2024
Alpha Biopharma Announces Completion of Its EVEREST Phase II/III Clinical Study of Zorifertinib in Non-Small Cell Lung Cancer Patients with Central Nervous System MetastasesAugust 25th, 2022
Innovent Release Phase 1 Results of IBI322 (Anti-PD-L1/CD47 Bispecific Antibody) in Patients with Advanced Solid Tumors at AACR Annual Meeting 2022April 11th, 2022
Join now to see all